Chronic pulmonary heart disease
disease diseaseOn this page
Also known as Cor pulmonale
Summary
Chronic pulmonary heart disease (MONDO:0001493) is a disease with 2 GWAS associations across 6 studies and 4 clinical trials. A subtype of cor pulmonale — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- GWAS associations: 2
- Clinical trials: 4
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | chronic pulmonary heart disease |
| Mondo ID | MONDO:0001493 |
| DOID | DOID:12326 |
| NCIT | C34478 |
| SNOMED CT | 87837008 |
| UMLS | C0238074 |
| MedGen | 116042 |
| Is cancer (heuristic) | no |
Also known as: Cor pulmonale
Data availability: 2 GWAS associations (6 studies).
Disease family
This is a subtype of cor pulmonale. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › cardiovascular disorder › heart disorder › heart failure › congestive heart failure › cor pulmonale › chronic pulmonary heart disease
Related subtypes (1): acute cor pulmonale
Subtypes (2): kyphoscoliotic heart disease, idiopathic pulmonary arterial hypertension
Genetics & variants
GWAS landscape
2 GWAS associations across 6 studies. Top hits map to 2 distinct genes (as reported by GWAS).
Top associations by p-value
| rsID | p-value | Gene | Risk allele | Odds ratio |
|---|---|---|---|---|
| rs964943276 | 5e-15 | NRXN1-DT | T | 1.84 |
| rs566015137 | 7e-08 | LINC01640 | ? |
Top studies (by case count)
| Study | Lead author | Year | Cases | Controls | Title |
|---|---|---|---|---|---|
| GCST90477878 | Verma A | 2024 | 11,655 | 427,349 | Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. |
| GCST90477877 | Verma A | 2024 | 3,527 | 115,145 | Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. |
| GCST90480140 | Verma A | 2024 | 3,527 | 115,145 | Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. |
| GCST90477876 | Verma A | 2024 | 908 | 57,929 | Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. |
| GCST90436084 | Zhou W | 2018 | 590 | 402,375 | Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. |
| GCST90651782 | Liu TY | 2025 | 572 | 233,745 | Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population. |
Variant details and genetic-evidence tiers
Tier distribution (top 50 variants)
| Tier | Variants |
|---|---|
| Tier 1: coding | 0 |
| Tier 2: splice/UTR | 0 |
| Tier 3: regulatory | 0 |
| Tier 4: intronic/intergenic | 2 |
MAF distribution
| Bucket | Variants |
|---|---|
| common (>=0.05) | 0 |
| low_freq (0.01-0.05) | 0 |
| rare (<0.01) | 1 |
| unknown | 1 |
Functional consequences
| Consequence | Count |
|---|---|
| intron_variant | 2 |
Top variants
| rsID | Chr | Pos | Alleles | MAF | Consequence | Gene | p-value | Tier |
|---|---|---|---|---|---|---|---|---|
| rs964943276 | 2 | 51590932 | T>C | 0.001 | intron_variant | NRXN1-DT | 5e-15 | Tier 4: intronic/intergenic |
| rs566015137 | 22 | 33085352 | A>C,G | intron_variant | LINC01640 | 7e-08 | Tier 4: intronic/intergenic |
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 4.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 4 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT00834145 | Not specified | UNKNOWN | Effect of Normatec Pump for Relief of Leg Edema in Patients With Right Heart Failure |
| NCT01554774 | Not specified | COMPLETED | Non-invasive Assessment of Pulmonary Vascular Resistance in Elderly Patients With Chronic Obstructive Pulmonary Disease |
| NCT02976324 | Not specified | COMPLETED | The Effect of External Diaphragmatic Pacemaker on the Patients With Chronic Cor Pulmonale |
| NCT03243994 | Not specified | COMPLETED | Small Intestinal Absorption in Patients With Chronic Obstructive Pulmonary Disease and Cor Pulmonale |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.